MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 25.936

Change

+0.20 (+0.76)%

Market Cap

N/A

Volume

1.50K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-0.53 (-0.88%)

USD 65.59B
QQQM Invesco NASDAQ 100 ETF

-0.34 (-0.16%)

USD 46.74B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.05 (-0.09%)

USD 25.59B
ACWI iShares MSCI ACWI ETF

-0.26 (-0.21%)

USD 19.99B
CGABL The Carlyle Group Inc. 4.625% ..

+0.25 (+1.50%)

USD 16.14B
TSLL Direxion Shares ETF Trust - Di..

-1.14 (-7.10%)

USD 6.20B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 5.83B
NVDL GraniteShares 1.5x Long NVDA D..

-3.52 (-6.32%)

USD 3.52B
USCL iShares Climate Conscious & Tr..

+0.03 (+0.04%)

USD 2.21B
ETHA iShares Ethereum Trust ETF

-0.60 (-2.99%)

USD 2.13B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.74% 41% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.74% 39% F 56% F
Trailing 12 Months  
Capital Gain -8.03% 22% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.03% 21% F 42% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.12% 32% F 40% F
Dividend Return -1.12% 25% F 36% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.02% 79% B- 95% A
Risk Adjusted Return -27.79% 20% F 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector